![Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. - Abstract - Europe PMC Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7577198/bin/jamainternmed-e206820-g002.jpg)
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. - Abstract - Europe PMC
![Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. - Abstract - Europe PMC Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7825875/bin/gr1_lrg.jpg)
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. - Abstract - Europe PMC
Supplementary Appendix (Authors list) Effect of Interleukin-6 Receptor Antagonists in Critically Ill Adult Patients with COVID-
![Cloé OKSENHENDLER | Université de Rennes 1, Rennes | UR1 | IDPSP - Institut du Droit Public et de la Science Politique | Research profile Cloé OKSENHENDLER | Université de Rennes 1, Rennes | UR1 | IDPSP - Institut du Droit Public et de la Science Politique | Research profile](https://i1.rgstatic.net/ii/profile.image/683925076717569-1540071853419_Q512/Cloe-Oksenhendler.jpg)